Virtus LifeSci Biotech Clinical Trials ETF (BBC) — ()
Key Metrics
News
Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026?
Published: by:
Sentiment: Positive ()
Wall Street put up a modest show in the final quarter of 2025, with the S&P 500 advancing only 1.9%, the Dow Jones gaining 3.3% and the Nasdaq Composite adding …
Read More
6 Best-Performing ETFs of Last Week
Published: by:
Sentiment: Neutral ()
Wall Street delivered mixed-to-downbeat performance last week thanks to Powell's warning of stagflation, rise of auto stocks on policy hopes, NVIDIA's $5.5B hit on export curb and upbeat retail sales.
Read More
About Virtus LifeSci Biotech Clinical Trials ETF BBC
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.